SEC Comment Letter 0000000000-25-003164 to TANDEM DIABETES CARE INC (TNDM)
TANDEM DIABETES CARE INC
Date: March 25, 2025 · CIK: 0001438133 · Accession: 0000000000-25-003164
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-36189
Letter
Re: TANDEM DIABETES CARE INC Form 10-K for the Year Ended December 31, 2024 Form 8-K Filed February 26, 2025 File No. 001-36189 Dear Leigh Vosseller:
March 25, 2025
Leigh Vosseller Executive Vice President, Chief Financial Officer and Treasurer TANDEM DIABETES CARE INC 12400 High Bluff Drive San Diego, California 92130
We have reviewed your filing and have the following comment.
Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments.
Form 8-K Filed February 26, 2025 Exhibit 99.1 Non-GAAP Measures, page 4
1. We note that your presentation of various non-GAAP measures includes an adjustment for Tandem Choice for which you disclose that the accounting treatment for Tandem Choice had a high degree of complexity. Please tell us how you concluded that this adjustment is appropriate and does not result in tailored accounting measures. Refer to Question 100.04 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretation for guidance. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. March 25, 2025 Page 2
Please contact Nudrat Salik at 202-551-3692 or Jeanne Baker at 202-551-3691 if you have questions regarding comments on the financial statements and related matters.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 25, 2025 Leigh Vosseller Executive Vice President, Chief Financial Officer and Treasurer TANDEM DIABETES CARE INC 12400 High Bluff Drive San Diego, California 92130 Re: TANDEM DIABETES CARE INC Form 10-K for the Year Ended December 31, 2024 Form 8-K Filed February 26, 2025 File No. 001-36189 Dear Leigh Vosseller: We have reviewed your filing and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 8-K Filed February 26, 2025 Exhibit 99.1 Non-GAAP Measures, page 4 1. We note that your presentation of various non-GAAP measures includes an adjustment for Tandem Choice for which you disclose that the accounting treatment for Tandem Choice had a high degree of complexity. Please tell us how you concluded that this adjustment is appropriate and does not result in tailored accounting measures. Refer to Question 100.04 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretation for guidance. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. March 25, 2025 Page 2 Please contact Nudrat Salik at 202-551-3692 or Jeanne Baker at 202-551-3691 if you have questions regarding comments on the financial statements and related matters. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services </TEXT> </DOCUMENT>